Berry Genomics Co.,Ltd (SHE:000710)
12.28
+0.07 (0.57%)
Feb 4, 2026, 3:04 PM CST
Berry Genomics Co.,Ltd Revenue
Berry Genomics Co.,Ltd had revenue of 238.22M CNY in the quarter ending September 30, 2025, a decrease of -12.06%. This brings the company's revenue in the last twelve months to 941.16M, down -15.09% year-over-year. In the year 2024, Berry Genomics Co.,Ltd had annual revenue of 1.08B, down -6.36%.
Revenue (ttm)
941.16M
Revenue Growth
-15.09%
P/S Ratio
4.61
Revenue / Employee
671.30K
Employees
1,402
Market Cap
4.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.08B | -73.25M | -6.36% |
| Dec 31, 2023 | 1.15B | -216.59M | -15.83% |
| Jan 1, 2023 | 1.37B | -54.17M | -3.81% |
| Jan 1, 2022 | 1.42B | -118.20M | -7.67% |
| Dec 31, 2020 | 1.54B | -77.26M | -4.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Maccura Biotechnology Co.Ltd | 2.21B |
| Shanghai Labway Clinical Laboratory | 1.52B |
| Medicalsystem Biotechnology | 1.47B |
| Beijing Strong Biotechnologies,Inc. | 1.43B |
| Thalys Medical Technology Group | 1.25B |
| Amoy Diagnostics | 1.13B |
| SMO ClinPlus CO.,LTD. | 819.09M |
| Cowealth Medical China | 777.03M |